News for Elanco Animal Health Inc Stock (ELAN)

Pomerantz Law Firm Announces the Filing of a Class Action Against Elanco Animal Health Incorporated and Certain Officers - ELAN

Accesswire • 10/08/24

US FDA approves Elanco's treatment for parasitic infections in dogs

Reuters • 10/07/24

Elanco Receives FDA Approval for Credelio Quattro™ (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets), the Broadest(i) Canine Oral Parasiticide Protection in a Single Monthly Dose

PRNewsWire • 10/07/24

Elanco Animal Health Incorporated Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Shareholder Participation

Accesswire • 10/03/24

Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Elanco Animal Health Incorporated For Possible Securities Fraud

Accesswire • 10/02/24

Elanco Animal Health Incorporated Is Being Investigated For Violating Securities Laws And The Schall Law Firm Urges Shareholder Participation

Accesswire • 10/01/24

Investors Are Invited To Join The Schall Law Firm's Inquiry Into Elanco Animal Health Incorporated For Possible Securities Fraud

Accesswire • 09/29/24

Elanco Animal Health Incorporated Is Being Investigated For Violating Securities Laws And The Schall Law Firm Encourages Stockholders To Participate

Accesswire • 09/28/24

The Schall Law Firm Is Looking Into Elanco Animal Health Incorporated For Possible Securities Fraud And Investors Are Urged To Reach Out

Accesswire • 09/27/24

Elanco Animal Health Incorporated Is Being Investigated For Violating Securities Laws And Affected Shareholders Should Contact The Schall Law Firm

Accesswire • 09/26/24

Investors Are Encouraged To Join The Schall Law Firm's Inquiry Into Elanco Animal Health Incorporated For Securities Fraud

Accesswire • 09/25/24

Elanco Animal Health Incorporated Is Being Investigated For Securities Law Violations And The Schall Law Firm Invites Shareholder Participation

Accesswire • 09/24/24

The Schall Law Firm Has Launched An Inquiry Into Elanco Animal Health Incorporated For Defrauding The Public And Affected Investors Are Urged To Join

Accesswire • 09/23/24

Elanco Animal Health Incorporated Is Being Investigated For Securities Law Violations And Stockholders Are Invited To Contact The Schall Law Firm

Accesswire • 09/22/24

The Schall Law Firm Urges Investor Participation In A Securities Fraud Inquiry Into Elanco Animal Health Incorporated

Accesswire • 09/21/24

Shareholders In Elanco Animal Health Incorporated Are Invited To Help The Schall Law Firm Look Into Possible Securities Law Violations

Accesswire • 09/20/24

Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy

Benzinga • 09/20/24

Elanco Announces FDA Approval and Launch of Zenrelia™ (ilunocitinib tablets), Offering An Effective, Safe Solution in Canine Dermatology

PRNewsWire • 09/19/24

FDA approves Elanco's dermatitis treatment for dogs

Reuters • 09/19/24

Elanco Animal Health Incorporated May Have Defrauded The Public And The Schall Law Firm Seeks Investor Participation In An Inquiry

Accesswire • 09/19/24

The Schall Law Firm Is Looking Into Elanco Animal Health Incorporated For Possible Securities Law Violations And Shareholders With Losses Should Reach Out

Accesswire • 09/18/24

Investors In Elanco Animal Health Incorporated Are Urged To Join The Schall Law Firm In A Securities Fraud Investigation

Accesswire • 09/17/24

The Schall Law Firm Is Looking Into Elanco Animal Health Incorporated For Possible Securities Related Infractions And Affected Shareholders Should Reach Out

Accesswire • 09/16/24

Investors With Losses In Elanco Animal Health Incorporated Are Invited By The Schall Law Firm To Participate In A Securities Fraud Inquiry

Accesswire • 09/15/24

Elanco Animal Health Incorporated Is Being Investigated For Securities Law Violations And The Schall Law Firm Urges Affected Stockholders To Reach Out

Accesswire • 09/14/24